3 research outputs found

    Borderline mucinous ovarian tumour – a rare bilateral presentation

    Get PDF
    Surface epithelial tumours are the most common ovarian tumours. According to the cell type, surface epithelial tumours can be serous, mucinous, endometrioid etc. Mucinous tumours of ovary are the neoplasms characterized by glandular, cystic architecture and are lined to variable extents by mucin-containing epithelium. Further these tumours are sub-classified into benign, borderline and malignant category. Typically, borderline tumours are non-invasive neoplasms that have nuclear abnormalities and mitotic activity intermediate between benign and malignant tumours of similar cell type. Borderline ovarian tumours are clinical entities less frequently encountered by pathologists and gynaecologists. Mucinous borderline ovarian tumours are among the most difficult ovarian neoplasms for surgical pathologists to interpret. They occur in younger women and present at an early stage. However, borderline tumours are difficult to diagnose correctly preoperatively using imaging methods because their macroscopic features overlap with invasive and benign ovarian tumours. Most importantly, these tumours have a superior prognosis when compared with ovarian carcinomas stage for stage. The borderline tumours may be of intestinal type or mullerian (endocervical like) type. The intestinal type tumours are by far the most common. Approximately 5% of the borderline mucinous tumours are bilateral. We here report a rare case of bilateral borderline mucinous tumours diagnosed on histopathology

    Borderline mucinous ovarian tumour and ndash; a rare bilateral presentation

    No full text
    Surface epithelial tumours are the most common ovarian tumours. According to the cell type, surface epithelial tumours can be serous, mucinous, endometrioid etc. Mucinous tumours of ovary are the neoplasms characterized by glandular, cystic architecture and are lined to variable extents by mucin-containing epithelium. Further these tumours are sub-classified into benign, borderline and malignant category. Typically, borderline tumours are non-invasive neoplasms that have nuclear abnormalities and mitotic activity intermediate between benign and malignant tumours of similar cell type. Borderline ovarian tumours are clinical entities less frequently encountered by pathologists and gynaecologists. Mucinous borderline ovarian tumours are among the most difficult ovarian neoplasms for surgical pathologists to interpret. They occur in younger women and present at an early stage. However, borderline tumours are difficult to diagnose correctly preoperatively using imaging methods because their macroscopic features overlap with invasive and benign ovarian tumours. Most importantly, these tumours have a superior prognosis when compared with ovarian carcinomas stage for stage. The borderline tumours may be of intestinal type or mullerian (endocervical like) type. The intestinal type tumours are by far the most common. Approximately 5% of the borderline mucinous tumours are bilateral. We here report a rare case of bilateral borderline mucinous tumours diagnosed on histopathology

    Report of a case of primary breast lymphoma highlighting the importance of fine needle aspiration cytology as an initial diagnostic tool

    No full text
    Primary non-Hodgkin lymphoma of breast is a rare pathology, representing 0.5% of malignant breast tumors. We report a case of 52 year old female presenting with a large painful mass in left breast with ipsilateral axillary lymph node diagnosed on fine needle aspiration cytology as non-Hodgkin′s lymphoma. Breast lymphoma should be differentiated from other breast malignancies because of the differences in their treatment modalities. When breast lymphoma presents as a lump with axillary node, it clinically mimics breast carcinoma. Ultrasonogram and mammogram shows no characteristic features that can distinguish it from other breast malignancy. In such cases, FNAC becomes an important diagnostic tool that can differentiate PBL from other breast malignancy and avoid unnecessary surgery
    corecore